Sign in
4

Changes in Ownership

Viridian Therapeutics, Inc.\DE Filed Acc 0000950170-24-039599

Director disposed of 5,859 shares (other)

  • Director acquired 5,859 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fairmount Funds Management LLC Director 2024-03-28 Other disposition −5,859 0 I
Fairmount Funds Management LLC Director 2024-03-28 Other acquisition +5,859 1,845,813 I
Derivatives
Fairmount Funds Management LLC Director 2024-03-28 Other disposition · Series A Non-Voting Convertible Preferred Stock −21,999 0 I
Fairmount Funds Management LLC Director 2024-03-28 Other acquisition · Series A Non-Voting Convertible Preferred Stock +21,999 133,191 I
Loading xslF345X05/ownership.xml…